Insider track record Other Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Dylan Jackson. Director active across 1 company, notably GSK plc. Cumulatively, 32 filings have been logged. History available since 9 August 2023. The latest transaction was filed on 11 July 2025 (Purchase). Regulator: RNS (LSE). All data is accessible without signup.
Declarations 32 total
● PCA of Sally Jackson ( SVP, Global Communications and CEO Office) · Executives · 9 Oct 2025 · GSK plc 0
GB00BN7SWP63⌘ RNS:5859068-17 Ideal exit: 6 Jul 2026 (T+270) ● PCA of Sally Jackson ( SVP, Global Communications and CEO Office) · Executives · 11 Jul 2025 · GSK plc 0
GB00BN7SWP63⌘ RNS:5739159-8 Ideal exit: 7 Apr 2026 (T+270) ● PCA of Ms S Jackson (SVP, Global Communications and CEO Office) · Executives · 11 Jul 2025 · GSK plc 1 shares @ £14.49 0.0% of flow GB00BN7SWP63⌘ RNS:5739159-1 Ideal exit: 7 Apr 2026 (T+270) ● PCA of Sally Jackson (SVP, Global Communications & CEO Office) · Executives · 19 Jun 2025 · GSK plc 1,395 shares @ £14.3524 3.2% of flow GB00BN7SWP63⌘ RNS:5709676-3 ● PCA of Sally Jackson (SVP, Global Communications & CEO Office) · Executives · 19 Jun 2025 · GSK plc 1,385 shares @ £14.3537 3.2% of flow GB00BN7SWP63⌘ RNS:5709676-4 Ideal exit: 16 Mar 2026 (T+270) ● PCA of Sally Jackson ( SVP, Global Communications and CEO Office) · Executives · 10 Apr 2025 · GSK plc 0
GB00BN7SWP63⌘ RNS:5617047-12 Ideal exit: 5 Jan 2026 (T+270) ● PCA of Ms S Jackson (SVP, Global Communications and CEO Office) · Executives · 10 Apr 2025 · GSK plc 1 shares @ £13.07 0.0% of flow GB00BN7SWP63⌘ RNS:5615070-19 Ideal exit: 5 Jan 2026 (T+270) ● PCA of Sally Jackson ( SVP, Global Communications and CEO Office) · Executives · 9 Jan 2025 · GSK plc 0
GB00BN7SWP63⌘ RNS:5498728-4 Ideal exit: 6 Oct 2025 (T+270) ● PCA of Ms S Jackson (SVP, Global Communications and CEO Office) · Executives · 9 Jan 2025 · GSK plc 1 shares @ £13.56 0.0% of flow GB00BN7SWP63⌘ RNS:5498728-13 Ideal exit: 6 Oct 2025 (T+270) ● PCA of Sally Jackson ( SVP, Global Communications and CEO Office) · Executives · 15 Oct 2024 · GSK plc 0
GB00BN7SWP63⌘ RNS:5393638-18 Ideal exit: 12 Jul 2025 (T+270) ● PCA of Ms S Jackson (SVP, Global Communications and CEO Office) · Executives · 10 Oct 2024 · GSK plc 1 shares @ £15.36 0.0% of flow GB00BN7SWP63⌘ RNS:5386817-11 Ideal exit: 7 Jul 2025 (T+270) ● PCA of Sally Jackson ( SVP, Global Communications and CEO Office) · Executives · 16 Jul 2024 · GSK plc 0
GB00BN7SWP63⌘ RNS:5272433-4 Ideal exit: 12 Apr 2025 (T+270) ● PCA of Ms S Jackson (SVP, Global Communications and CEO Office) · Executives · 11 Jul 2024 · GSK plc 1 shares @ £15.08 0.0% of flow GB00BN7SWP63⌘ RNS:5266837-17 Ideal exit: 7 Apr 2025 (T+270) ● PCA of Sally Jackson (SVP, Global Communications & CEO Office) · Executives · 16 May 2024 · GSK plc 1,120 shares @ £17.87 3.4% of flow GB00BN7SWP63⌘ RNS:5190094-2 ● PCA of Sally Jackson (SVP, Global Communications & CEO Office) · Executives · 16 May 2024 · GSK plc 1,112 shares @ £17.874 3.4% of flow GB00BN7SWP63⌘ RNS:5190094-3 Ideal exit: 10 Feb 2025 (T+270) ● PCA of Sally Jackson ( SVP, Global Communications and CEO Office) · Executives · 16 Apr 2024 · GSK plc 0
GB00BN7SWP63⌘ RNS:5149697-4 Ideal exit: 11 Jan 2025 (T+270) ● PCA of Ms S Jackson (SVP, Global Communications and CEO Office) · Executives · 11 Apr 2024 · GSK plc 24 shares @ £16.2892 0.1% of flow GB00BN7SWP63⌘ RNS:5143847-19 Ideal exit: 6 Jan 2025 (T+270) ● PCA of Ms S Jackson (SVP, Global Communications and CEO Office) · Executives · 9 Feb 2024 · GSK plc 3,592 shares @ £16.6055 10.9% of flow GB00BN7SWP63⌘ RNS:5066290-8 ● PCA of Ms S Jackson (SVP, Global Communications and CEO Office) · Executives · 9 Feb 2024 · GSK plc 7,642 shares 0
GB00BN7SWP63⌘ RNS:5066290-7 ● PCA of Ms S Jackson (SVP, Global Communications and CEO Office) · Executives · 9 Feb 2024 · GSK plc 7,642 shares 0
GB00BN7SWP63⌘ RNS:5066262-7 ● PCA of Ms S Jackson (SVP, Global Communications and CEO Office) · Executives · 9 Feb 2024 · GSK plc 3,592 shares @ £16.6055 10.9% of flow GB00BN7SWP63⌘ RNS:5066262-8 ● PCA of Sally Jackson ( SVP, Global Communications and CEO Office) · Executives · 16 Jan 2024 · GSK plc 0
GB00BN7SWP63⌘ RNS:5039401-4 Ideal exit: 12 Oct 2024 (T+270) ● PCA of Ms S Jackson (SVP, Global Communications and CEO Office) · Executives · 11 Jan 2024 · GSK plc 21 shares @ £15.721 0.1% of flow GB00BN7SWP63⌘ RNS:5034561-19 Ideal exit: 7 Oct 2024 (T+270) ● PCA of Sally Jackson (SVP, Global Communications and CEO Office) · Executives · 23 Oct 2023 · GSK plc 6,330 shares 0
GB00BN7SWP63⌘ RNS:4948264-0 ● PCA of Sally Jackson (SVP, Global Communications and CEO Office) · Executives · 23 Oct 2023 · GSK plc 2,976 shares @ £14.6434 26.8% of flow GB00BN7SWP63⌘ RNS:4948264-1 25 of 32 declarations
Load more (7 remaining) About Dylan Jackson Dylan Jackson is a declarant associated with GSK plc, where he is PCA of Sally Jackson (SVP, Global Communications and CEO Office). He has made 32 filings in total, all sampled, with a total buy amount of 48,248 EUR and a total sell amount of 269,821 EUR. The first filing date is August 10, 2023, and the last filing date is October 13, 2025. Among his recent filings, he reported a purchase of 102,450.45 EUR on September 11, 2023, and multiple sales on February 13, 2024, totaling 69,842.41 EUR each, as well as a sale of 50,027.54 EUR and another of 33,334.88 EUR on October 25, 2023.